Zomedica Corp (NYSEAMERICAN:ZOM) jumped 20% from this week’s lows, and traders are optimistic for more gains The veterinarians’ medical devices maker gained without any news, but the stock doesn’t need any news to fall or rise since it is in the penny market region.
Investors need to be keen on these kinds of stocks because they can fall instantly, just as quickly as they gain.
With that said, there has been discussion in StockTwits by Zomedica investors on the stock. For instance, Jonathan Godinez indicated after Qorvo settles the suit, Zomedica is likely to surge. He said that Heska is employing the law system to stall Qorvo, their competitor. Another investor indicated that Zomedica has been through a reversal pattern, and correction is complete, and next week it could jump to $2.5.
Similarly, Vanguard added stock to their ETFs, and it could be good to follow that institutional money. Zomedica is up 164.3% year to date, and in the coming weeks, this is a stock to keep an eye on.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.